GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...

However, sales have been slowing. In the second quarter of this year, GSK reported that Shingrix sales dropped 4% ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two ... Fasenra has been shut out in its attempts to expand to new ...

(Reuters) – British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with ...

LOUISVILLE, Ky. (WDRB) -- Kids at the Shawnee Community Center designed 25 banners that now line West Broadway from 28th Street to Shawnee Park, showing off the cultural heritage of west Louisville.

The GSK share price is nearly 10% off its 52-week high, and this Fool is keen to take a closer look. Could it be a stock for ...

At the LSX (Life Sciences Executive) World Congress in Boston, leaders in biotech, healthtech, and medtech will gather to ...

GSK’s twice-yearly depemokimab reduced asthma attacks by half and cut clinic visits by nearly three-quarters, positioning it ...